關鍵數據
8.650今開
9.400最高
23.21K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.07%換手率
8.600昨收
8.650最低
212.30K成交額
虧損本益比靜
10.76市淨率
0.00%股息率 TTM
-47.08%ROA
19.63052週最高
0.03量比
-18.91M淨利潤
32.05M總股本
-1.0079每股盈餘TTM
1.30Beta
-149.72%ROE
8.27052週最低
13.02%振幅
58.46%毛利率
293.90M總市值
0.41回報/風險
5.39%風險率

即將為您帶來更多新聞,敬請期待。 。 。
Clearpoint Neuro Inc評分
0.06與上次評分對比預測9.00
財務診斷6.38
技術分析5.49
公司估值7.86
機構認同度5.00
風險評估3.70
分析師評級
強力買入評級
21.500目標均價
+101.50%漲幅空間
Clearpoint Neuro Inc 最新財報電話會記錄
ClearPoint Neuro (CLPT) 2026年第三季法說會:營收成長36%,2027年利多因素在即
ClearPoint Neuro 2026 年第三季財報電話會議:營收成長 36% 至 1,210 萬美元,現金達 4,620 萬美元,管理層並概述了 2027 年的主要催化劑。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Clearpoint Neuro Inc 簡介
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
行業醫療設備與耗材
公司代碼CLPT
員工數量115
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| BlackRock Institutional Trust Company, N.A. | 6.04% |
|---|
| MAK Capital One, LLC | 5.77% |
|---|
| Bigger Capital Funds, LP | 4.54% |
|---|
| Vanguard Capital Management, LLC | 4.15% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 24.64% |
|---|
| Hedge Fund | 15.56% |
|---|
| Investment Advisor/Hedge Fund | 9.43% |
|---|
| Individual Investor | 5.49% |
|---|
常見問題
Clearpoint Neuro Inc(CLPT)的當前股價是多少?
Clearpoint Neuro Inc(CLPT)的當前股價是 9.17。
Clearpoint Neuro Inc 的股票代碼是什麼?
Clearpoint Neuro Inc的股票代碼是CLPT。
Clearpoint Neuro Inc股票的52週最高點是多少?
Clearpoint Neuro Inc股票的52週最高點是19.63。
Clearpoint Neuro Inc股票的52週最低點是多少?
Clearpoint Neuro Inc股票的52週最低點是8.27。
Clearpoint Neuro Inc的市值是多少?
Clearpoint Neuro Inc的市值是293.90M。
現在Clearpoint Neuro Inc(CLPT)的股票是買入、持有還是賣出?
根據分析師評級,Clearpoint Neuro Inc(CLPT)的總體評級為STRONG BUY,目標價格為21.50。
Clearpoint Neuro Inc(CLPT)股票的每股收益(EPS TTM)是多少
Clearpoint Neuro Inc(CLPT)股票的每股收益(EPS TTM)是-1.01。